AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 29 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $382,000 | +6.4% | 2,615,632 | +9.4% | 0.00% | – |
| Q3 2019 | $359,000 | +14.7% | 2,391,788 | +22.3% | 0.00% | – |
| Q2 2019 | $313,000 | +46.3% | 1,955,391 | +79.1% | 0.00% | – |
| Q1 2019 | $214,000 | +375.6% | 1,091,917 | +1583.1% | 0.00% | – |
| Q4 2018 | $45,000 | +28.6% | 64,877 | +125.5% | 0.00% | – |
| Q3 2018 | $35,000 | -74.3% | 28,770 | -63.4% | 0.00% | – |
| Q2 2018 | $136,000 | +25.9% | 78,570 | +46.3% | 0.00% | – |
| Q1 2018 | $108,000 | -3.6% | 53,700 | -42.6% | 0.00% | – |
| Q4 2017 | $112,000 | +489.5% | 93,600 | +515.8% | 0.00% | – |
| Q3 2017 | $19,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $142,000 | 0.10% |
| Baker Brothers Advisors | 4,055,142 | $4,501,000 | 0.03% |
| WEDBUSH SECURITIES INC | 209,524 | $233,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,105,000 | 0.01% |
| Verity Asset Management, Inc. | 11,500 | $13,000 | 0.01% |
| OneDigital Investment Advisors LLC | 11,437 | $13,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $17,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 120,619 | $134,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $3,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $2,000 | 0.00% |